首页> 外文期刊>Journal of Medicinal Chemistry >Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling
【24h】

Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling

机译:开发无七同源物 1 (SOS1) 调节剂通过调节 RAS 信号传导治疗癌症

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Son of sevenless homologue 1 (SOS1) protein is universally expressed in cells and plays an important role in the RAS signaling pathway. Specifically, this protein interacts with RAS in response to upstream stimuli to promote guanine nucleotide exchange in RAS and activates the downstream signaling pathways. Thus, targeting SOS1 is a new approach for treating RAS-driven cancers. In this Perspective, we briefly summarize the structural and functional aspects of SOS1 and focus on recent advances in the discovery of activators, inhibitors, and PROTACs that target SOS1. This review aims to provide a timely and updated overview on the strategies for targeting SOS1 in cancer therapy.
机译:七无同源物 1 (SOS1) 蛋白的儿子在细胞中普遍表达,并在 RAS 信号通路中起重要作用。具体来说,这种蛋白质响应上游刺激与 RAS 相互作用,促进 RAS 中的鸟嘌呤核苷酸交换并激活下游信号通路。因此,靶向SOS1是治疗RAS驱动癌症的一种新方法。在本期文章中,我们简要总结了 SOS1 的结构和功能方面,并重点介绍了靶向 SOS1 的激活剂、抑制剂和 PROTAC 发现的最新进展。本综述旨在对癌症治疗中靶向SOS1的策略进行及时和最新的概述。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号